Merck and EyeBio Initiate Phase 2b/3 Trial for Diabetic Macular Edema
04 Sep 2024 //
BUSINESSWIRE
Merck Completes Acquisition of EyeBio
12 Jul 2024 //
PRESS RELEASE
Merck to Acquire EyeBio
29 May 2024 //
BUSINESSWIRE
Merck nears $1.3 bln cash deal for eye-drug company EyeBio, WSJ reports
29 May 2024 //
REUTERS
EyeBio targets registrational trial after early success of Wnt agonist
13 Feb 2024 //
ENDPTS
EyeBio Announces Expansion of Series A to $130 Million
14 Nov 2023 //
BUSINESSWIRE